EUVIMEDEUVIMED entdecken
Crossref

Genome diversity and evolutionary understanding of Lassa virus: a holistic approach highlighting a potential target for cross-lineage vaccine development

Moshood Olamide Lateef, Abideen Titilope Aransi, Dauda Nathaniel

Archives of Virology · 2026

DOI: 10.1007/s00705-025-06481-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Virology, 2026. Verfasst von Moshood Olamide Lateef und 2 weiteren Autor:innen. Beteiligte Einrichtung: Virology and Molecular Diagnostics Unit, International Institute of Tropical Agriculture, Ibadan, Nigeria. m.lateef@cgiar.org. Hauptthemen laut MEDLINE: Lassa virus, Genetic Variation, Genome, Viral, Evolution, Molecular. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies on the genetic diversity of Lassa virus (LASV) have often relied on sequences containing undetermined nucleotides. In this study, we analyzed open reading frame (ORF) sequences free of undetermined nucleotides to assess LASV diversity with improved accuracy. The calculated pairwise identity was ≥ 68% for the polymerase, ≥ 74% for the nucleoprotein (NP), and ≥ 75% for the glycoprotein (GP) genes. LASV strains were classified into seven established lineages. Notably, lineage VI (represented by strain KT992435.1_KAK-428) exhibited phylogenetic relatedness to all other lineages, suggesting that it may retain ancestral traits. This observation underscores the potential evolutionary significance of its rodent host, Hylomyscus pamfi. A multiple sequence alignment of the GP gene revealed a unique codon insertion present only in lineages IV and V. The GP from these two lineages showed a predicted antigenicity score of 0.66, which is lower than the maximum scores observed in other lineages. Nonetheless, all lineage representatives were predicted to be non-allergenic and non-toxic and possessed a moderate density of B- and T-cell epitopes with ≥ 90% conservation. Considering the observed genetic divergence, antigenic variation, and epitope conservation, lineage VI (KAK-428) is proposed as a potential target for the development of a broadly protective LASV vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa virusGenetic VariationGenome, ViralEvolution, MolecularLassa FeverViral VaccinesPhylogenyAnimalsVaccine DevelopmentOpen Reading FramesEpitopes, T-LymphocyteViral ProteinsEpitopes, B-Lymphocyte

Substanzen

Viral VaccinesEpitopes, T-LymphocyteViral ProteinsEpitopes, B-Lymphocyte

Autor:innen und Institutionen

  • Virology and Molecular Diagnostics Unit, International Institute of Tropical Agriculture, Ibadan, Nigeria. m.lateef@cgiar.org.
  • Virology and Molecular Diagnostics Unit, International Institute of Tropical Agriculture, Ibadan, Nigeria.
  • Department of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Department of Crop Sciences, Faculty of Agriculture, University of Nigeria, Nsukka, Nigeria.

Zitieren

APA

Lateef, M. O., Aransi, A. T., & Nathaniel, D. (2026). Genome diversity and evolutionary understanding of Lassa virus: a holistic approach highlighting a potential target for cross-lineage vaccine development. Archives of Virology. https://doi.org/10.1007/s00705-025-06481-5

Vancouver

Lateef MO, Aransi AT, Nathaniel D. Genome diversity and evolutionary understanding of Lassa virus: a holistic approach highlighting a potential target for cross-lineage vaccine development. Archives of Virology. 2026. doi:10.1007/s00705-025-06481-5

BibTeX
@article{Lateef2026,
  author = {Lateef, Moshood Olamide and Aransi, Abideen Titilope and Nathaniel, Dauda},
  title = {Genome diversity and evolutionary understanding of Lassa virus: a holistic approach highlighting a potential target for cross-lineage vaccine development},
  journal = {Archives of Virology},
  year = {2026},
  doi = {10.1007/s00705-025-06481-5}
}
Kostenlos starten →